LEARNING OPPORTUNITY: Harvard T.H. Chan School of Public Health is offering an online course on Benefit-Cost Analysis: Valuing Life and Health from September, 16-20, 2024, led by Lisa A Robinson. Find out more and register: ow.ly/nuAU50RsKPU

New evidence on the cost of delivering #COVID -19 vaccines in DRC on day 2 of #WIW24 : A study from ThinkWell and the Ecole de Santé Publique de Kinshasa-ESP found a high financial unit cost of US$2.18 due to low delivery volumes. Read the study report: ow.ly/jcAe50RohYw

We asked a range of key decision-makers what they need to know to about potential new vaccines

The results were..... Alot, and WHO's Full Value of Vaccine Assessments framework helps

But FVVAs could be even more useful

Our new paper gives 3 ways FVVAs could be even better:

🚨 New research shows stakeholders from areas at risk of #chikungunya outbreaks prioritise vaccination differently but share similar concerns.

Involving stakeholders at all stages of #vaccine development and rollout will help ensure vaccine equity.

👉 journals.plos.org/plosntds/artic…

Register for the Disease and Program Costing in Global Health Programs course hosted by the Global Health Systems Summer Institute and Johns Hopkins Bloomberg School of Public Health. The course will be held online from June 24-28. Find out more here: ow.ly/gm7Y50RcqoN

.CHAI has launched a Vaccine Procurement Diagnostic Toolkit for country immunization programs, designed to assist immunization programs in assessing, diagnosing, and solving #vaccine procurement challenges. You can access it directly here: ow.ly/5eY950RcJOl

A recent commentary in HealthPolicyPlanning from Chiamaka Ojiako of NYU Wagner, discusses the path towards increasing self-reliance for #vaccine manufacturing in #Africa . Read the piece here: ow.ly/NtCL50R8rHW

New funding opportunity: we’re looking for modelled estimates of the health impacts of expanding the upper age limit of supplementary immunisation activities (SIAs) for measles vaccination.
Closing date: 15 April
vaccineimpact.org/requests-for-p…
#requestforproposals #vaccineswork #measles

What policy questions around the #HPV vaccine introduction can be addressed with evidence from mathematical models? 💉♀️

Join my presentation on the #HPV vaccine introduction in Mozambique at CEMA-Africa today!

🚨New Postdoc Alert!🚨
Please share widely!
Come work with me Harvard T.H. Chan School of Public Health on topics in #healtheconomics #maternalhealth #healthpolicy #behavioraleconomics

Two year position starting this summer.
Details below ⬇️
academicpositions.harvard.edu/postings/13483…

It was great to have Kevin from Institute for Disease Modeling speak to us about his important #measles modeling work, and give advice to our Center for Health Decision Science trainees

New #Vaccine publication: Modelling new TB #vaccines in South Africa 🇿🇦

Vaccines were found to be impactful and cost-effective or cost-saving across a range of characteristics and delivery strategies

CMMID LSHTM TB Centre Vaccine Centre @LSHTM

doi.org/10.1016/j.vacc…

.ThinkWell is updating the Immunization Delivery Cost Catalogue, the most comprehensive, standardized global evidence on the cost of delivering vaccines, & welcomes researchers to share studies on the cost of immunization delivery. Share your work: ow.ly/URbC50Qw3sG

.ThinkWell is updating the Immunization Delivery Cost Catalogue and welcomes researchers to share any studies they have conducted on the cost of delivering immunization. Find out how to share your work: ow.ly/JTiU50QrkK7

A new study led by Imperial College London found that introducing the R21/Matrix-M malaria vaccine across sub-Saharan Africa could have a substantial public health benefit and has cost-effectiveness ratios similar to those of other malaria interventions: ow.ly/tHvi50QkMY2

🚨 Newest work out in BMJ_Open

Collaborating with Vishy Pingali Advance Access & Delivery - Durham Team Advance Access & Delivery (AA&D) Salmaan Keshavjee Boston University School of Public Health BU_TIARA Harvard Medical School

We estimate the economic impact of not finding and treating a patient with #tuberculosis in the Indian context.

bmjopen.bmj.com/content/13/12/…

'📢 Just published: Our new modeling study shows primary HPV testing is the most effective and cost-effective screening approach in 78 low-and lower-middle income countries. A companion paper by Michaela Hall found primary HPV screening was also optimal for women living with HIV.

.Amber E. Barnato MD and I are honored to co-chair the 46th annual meeting of Society for Medical Decision Making (SMDM) in Boston in 2024. This year's theme will be The Future of Medical Decision Making in the Era of #GenerativeAI AI. Stay tuned for some exciting announcements in the coming weeks.

The London School of Hygiene & Tropical Medicine is offering a PhD opportunity to create evidence for novel TB vaccine introduction. The evidence from this work will support countries in their TB vaccine introduction decision-making. The deadline for applications is January 16, 2024: ow.ly/TgxM50Qi4HC

🔜 I’ll be recruiting a number of post-docs and Phd students to my new group in Berlin.

If interested and keen on vaccine epidemiology, global health and disease dynamics, including eg modelling, stats, RSV, Pneumo, Dengue, pandemic preparedness, please get in touch